Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | NRAS |
| Variant | G12V |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | NRAS G12V is a hotspot mutation that lies within a GTP-binding region of the Nras protein (UniProt.org). G12V confers a loss of function on Nras protein as indicated by accumulation of GTP-bound Nras, loss of GTPase-activating protein sensitivity (PMID: 19966803), leading to increased Erk and Stat5 phosphorylation and transforming activity in cell culture (PMID: 19966803, PMID: 35211470). |
| Associated Drug Resistance | |
| Category Variants Paths |
NRAS mutant NRAS act mut NRAS G12V NRAS mutant NRAS exon2 NRAS G12X NRAS G12V |
| Transcript | NM_002524.5 |
| gDNA | chr1:g.114716126C>A |
| cDNA | c.35G>T |
| Protein | p.G12V |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002524.4 | chr1:g.114716126C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
| NM_002524.5 | chr1:g.114716126C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
| NM_002524 | chr1:g.114716126C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03190941 | Phase Ib/II | Cyclophosphamide anti-KRAS G12V mTCR cells Fludarabine Aldesleukin | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | Recruiting | USA | 0 |
| NCT05726864 | Phase Ib/II | ELI-002 | A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors (AMPLIFY-7P) | Active, not recruiting | USA | 0 |